Genomic Health prostate cancer test

New Prostate Cancer Test Improves Risk Assessment

“Active surveillance is increasingly acknowledged as a preferred strategy for most men with low-risk disease, but in practice it is used relatively infrequently, ” he noted. “There are many reasons why – financial, legal and cultural among others. Many men don’t want to live with anxiety over the chances of their disease progressing. So we need to predict with better accuracy which tumors harbor metastatic potential. If we are able to risk-stratify men more consistently and identify a greater proportion for active surveillance, we should be able to ameliorate overtreatment rates, and by extension help resolve the ongoing debate about PSA screening.”

The second most common cancer in men, prostate cancer affects about one man in six, according to the American Cancer Society. Typically the disease occurs in older men – the average age at diagnosis is about 67 – and an aggressive form kills as many as 30, 000 men annually in the U.S. Most men, however, do not die from the disease because they have relatively indolent, low-risk tumors that do not progress even without treatment.

Active surveillance involves closely monitoring a patient’s condition through serial PSA screening and prostate biopsies, but otherwise the disease is not treated unless tests show the condition is getting worse. Active surveillance is not entirely benign – biopsies are uncomfortable and carry a risk of bleeding and infection. Moreover, some patients experience a higher level of anxiety over the potential of their cancers to advance.

While active surveillance can help patients avoid or delay surgery or radiation, scientists have faced a major challenge: how to identify – consistently and reliably – which patients can safely embark on it and which patients face clinically meaningful risk of disease progression.

A genomic breakthrough in prostate cancer management: new tests may help doctors separate prostate tumors that require treatment from those needing ... An article from: Men's Health Advisor
Book (Belvoir Media Group, LLC)

Change is futile

by bornagaingumby

In a small study, the researchers tracked 30 men with low-risk prostate cancer who decided against conventional medical treatment such as surgery and radiation or hormone therapy.
The men underwent three months of major lifestyle changes, including eating a diet rich in fruits, vegetables, whole grains, legumes and soy products, moderate exercise such as walking for half an hour a day, and an hour of daily stress management methods such as meditation.
As expected, they lost weight, lowered their blood pressure and saw other health improvements. But the researchers found more profound changes when they compared prostate biopsies taken before and after the lifestyle changes

Drink to your health - a new product.

by daisydo

Pomegranate juice. It's antioxidant-rich.
By Erika Engelhaupt For The Inquirer
First it was red wine. Then green tea. Now pomegranate juice is making the rounds as the latest good-for-you drink.
It may help lower blood pressure and even fight certain cancers, but research is preliminary. Beware extra calories if you swill a daily dose.
Sales of refrigerated pomegranate juice soared from zero in 2001 to more than $63 million in 2005.
Antioxidants stop free radicals from attacking LDL, or "bad" cholesterol, and combining with cells to form plaque that hardens arteries

You might also like:
NICTA: Prostate Cancer Genomics Research
NICTA: Prostate Cancer Genomics Research
Prostate Cancer Test Warnings Seemingly Ignored
Prostate Cancer Test Warnings Seemingly Ignored

Premature ejaculation a common problem among Vietnamese men: survey  — Thanh Nien Daily
It shows that up to 30 percent of the respondents reported suffering from premature ejaculation, of them only 23 percent consulted a doctor and 52 percent openly talked with their spouse about the issue.

Academic Press Genomic and Personalized Medicine: V1-2
eBooks (Academic Press)
Urine test shows prostate cancer risk
Urine test shows prostate cancer risk
New prostate cancer test may prevent overtreatment
New prostate cancer test may prevent overtreatment
Prostate cancer screening.(GENOMIC MEDICINE): An article from: Family Practice News
Book (International Medical News Group)
Academic Press The Path from Biomarker Discovery to Regulatory Qualification
eBooks (Academic Press)
Academic Press Bone Cancer: Progression and Therapeutic Approaches
eBooks (Academic Press)
Related Posts